Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma

Affiliations

¹ Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea.
² Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
³ Department of Hematology-Oncology, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea.
⁴ Department of Hematology-Oncology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
⁵ Department of Hematology- Oncology, Inje University Haeundae Paik Hospital, Busan, Korea.
⁶ Department of Hematology-Oncology, Dong-A University Hospital, Busan, Korea.
⁷ Department of Hematology-Oncology, Daegu Catholic University Hospital, Daegu Catholic University School of Medicine, Daegu, Korea.
⁸ Department of Hematology-Oncology, Keimyung University School of Medicine, Daegu, Korea.
⁹ Department of Hematology-Oncology, Inje University Busan Paik Hospital, Busan, Korea.
¹⁰ Department of Hematology-Oncology, Yeungnam University Hospital, Daegu, Korea.

Published Erratum

Hee Jeong Cho et al. Korean J Intern Med. 2023 Jul.

. 2023 Jul;38(4):578.

doi: 10.3904/kjim.2022.183e. Epub 2023 Jun 9.

¹ Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea.
² Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
³ Department of Hematology-Oncology, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea.
⁴ Department of Hematology-Oncology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
⁵ Department of Hematology- Oncology, Inje University Haeundae Paik Hospital, Busan, Korea.
⁶ Department of Hematology-Oncology, Dong-A University Hospital, Busan, Korea.
⁷ Department of Hematology-Oncology, Daegu Catholic University Hospital, Daegu Catholic University School of Medicine, Daegu, Korea.
⁸ Department of Hematology-Oncology, Keimyung University School of Medicine, Daegu, Korea.
⁹ Department of Hematology-Oncology, Inje University Busan Paik Hospital, Busan, Korea.
¹⁰ Department of Hematology-Oncology, Yeungnam University Hospital, Daegu, Korea.

No abstract available

Erratum for

Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/ refractory multiple myeloma.
Cho HJ, Jo JC, Lee YJ, Lee MW, Kim DY, Shin HJ, Im SN, Lee JH, Bae SH, Do YR, Lee WS, Kim MK, Jung J, Lee JM, Kim JH, Baek DW, Sohn SK, Moon JH. Cho HJ, et al. Korean J Intern Med. 2023 Mar;38(2):238-247. doi: 10.3904/kjim.2022.183. Epub 2023 Jan 26. Korean J Intern Med. 2023. PMID: 36698051 Free PMC article.